Aflibercept in the clinical routine: the AURIGA study. The 24-month results of the German cohort of treatment-naïve patients with diabetic macular edema receiving intravitreal aflibercept

Background: AURIGA is the largest prospective real-world study to evaluate intravitreal aflibercept (IVT-AFL) treatment of diabetic macular edema (DME) and macular edema secondary to retinal vein occlusion. This article presents 24-month data from the German cohort of treatment-na & iuml;ve patients with DME. Methods: Treatment-na & iuml;ve patients (>= 18 years) with DME were treated with IVT-AFL at the discretion of the physician in clinical practice. The primary endpoint was mean change in visual acuity (early treatment diabetic retinopathy, ETDRS, letters) at month 12 compared to baseline. Statistical analyses were descriptive. Results: The analysis included data from 150 DME patients (54.7% male). At months 6, 12 and 24, mean (95% confidence interval) visual acuity gains of 4.6 (2.6; 6.5), 4.0 (2.1; 6.5) and 5.0 (3.0; 6.9) letters from baseline (mean +/- SD: 65.0 +/- 15.3 letters) and reductions in retinal thickness of 86 mu m (109; 64 mu m), 70 mu m (94; 43 mu m) and 75 mu m (103; 47 mu m) from baseline (mean +/- SD: 391 +/- 132 mu m), respectively, were achieved. At month 24, 54% of patients gained >= 5 letters and 22% >= 15 letters. Patients received a mean number of 5.0 +/- 1.6 injections until month 6, 7.1 +/- 3.2 until month 12 and 9.0 +/- 5.3 until month 24, 68% of patients received >= 5 injections until month 6 and 56% >= 7 injections within the first year. The safety profile was consistent with previous studies. Discussion: In the German AURIGA cohort, treatment-na & iuml;ve DME patients achieved a clinically relevant gain in visual acuity as well as reduction in central retinal thickness following IVT-AFL treatment in clinical practice. From month 6 onwards, improvements were maintained despite a low injection frequency over 24 months. In comparison with previous real-world studies, care of DME patients in clinical practice seems to have improved; however, there is still room for further improvement.